270 related articles for article (PubMed ID: 30049704)
1. ICAM-1 controls development and function of ILC2.
Lei AH; Xiao Q; Liu GY; Shi K; Yang Q; Li X; Liu YF; Wang HK; Cai WP; Guan YJ; Gabrilovich DI; Zhou J
J Exp Med; 2018 Aug; 215(8):2157-2174. PubMed ID: 30049704
[TBL] [Abstract][Full Text] [Related]
2. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
3. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
Front Immunol; 2021; 12():667922. PubMed ID: 34194431
[TBL] [Abstract][Full Text] [Related]
4. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
5. β
Karta MR; Rosenthal PS; Beppu A; Vuong CY; Miller M; Das S; Kurten RC; Doherty TA; Broide DH
J Allergy Clin Immunol; 2018 Jan; 141(1):329-338.e12. PubMed ID: 28366795
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.
Zhou W; Toki S; Zhang J; Goleniewksa K; Newcomb DC; Cephus JY; Dulek DE; Bloodworth MH; Stier MT; Polosuhkin V; Gangula RD; Mallal SA; Broide DH; Peebles RS
Am J Respir Crit Care Med; 2016 Jan; 193(1):31-42. PubMed ID: 26378386
[TBL] [Abstract][Full Text] [Related]
7. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
9. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
11. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
[TBL] [Abstract][Full Text] [Related]
12. Spred1, a Suppressor of the Ras-ERK Pathway, Negatively Regulates Expansion and Function of Group 2 Innate Lymphoid Cells.
Suzuki M; Morita R; Hirata Y; Shichita T; Yoshimura A
J Immunol; 2015 Aug; 195(3):1273-81. PubMed ID: 26116510
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E
Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
Front Immunol; 2018; 9():501. PubMed ID: 29593738
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
15. Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
Mathä L; Shim H; Steer CA; Yin YH; Martinez-Gonzalez I; Takei F
PLoS One; 2019; 14(3):e0214286. PubMed ID: 30913260
[TBL] [Abstract][Full Text] [Related]
16. COX Inhibition Increases
Zhou W; Zhang J; Toki S; Goleniewska K; Norlander AE; Newcomb DC; Wu P; Boyd KL; Kita H; Peebles RS
J Immunol; 2020 Aug; 205(4):1157-1166. PubMed ID: 32690653
[TBL] [Abstract][Full Text] [Related]
17. A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and
Yuan F; Jiang L; Li Q; Sokulsky L; Wanyan Y; Wang L; Liu X; Zhou L; Tay HL; Zhang G; Yang M; Li F
Front Immunol; 2020; 11():598165. PubMed ID: 33597946
[TBL] [Abstract][Full Text] [Related]
18. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.
Orimo K; Tamari M; Takeda T; Kubo T; Rückert B; Motomura K; Sugiyama H; Yamada A; Saito K; Arae K; Kuriyama M; Hara M; Soyka MB; Ikutani M; Yamaguchi S; Morimoto N; Nakabayashi K; Hata K; Matsuda A; Akdis CA; Sudo K; Saito H; Nakae S; Tamaoki J; Tagaya E; Matsumoto K; Morita H
Allergy; 2022 Mar; 77(3):843-855. PubMed ID: 34402091
[TBL] [Abstract][Full Text] [Related]
19. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
20. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
